Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 28;18(1):340.
doi: 10.1186/s12882-017-0770-8.

VDJ gene usage among B-cell receptors in ABO-incompatible kidney transplantation determined by RNA-seq Transcriptomic analysis

Hee Jung Jeon  1 , Kwangsoo Kim  2 , Jae-Ghi Lee  3 , Joon Young Jang  3 , Seongmin Choi  2 , Taishi Fang  3 , Ji-Jing Yan  3 , Miyeun Han  4 , Jong Cheol Jeong  5 , Kyoung-Bun Lee  6 , Tae Jin Kim  7 , Curie Ahn  3   4   8 , Jaeseok Yang  9   10   11
Affiliations

VDJ gene usage among B-cell receptors in ABO-incompatible kidney transplantation determined by RNA-seq Transcriptomic analysis

Hee Jung Jeon et al. BMC Nephrol. .

Abstract

Background: Studies on B-cell subtypes and V(D)J gene usage of B-cell receptors in kidney transplants are scarce. This study aimed to investigate V(D)J gene segment usage in ABO-incompatible (ABOi) kidney transplant (KT) patients compared to that in ABO-compatible (ABOc) KT patients.

Methods: We selected 16 ABOi KT patients with accommodation (ABOiA), 6 ABOc stable KT patients (ABOcS), and 6 ABOi KT patients with biopsy-proven acute antibody-mediated rejection (ABOiR) at day 10, whose graft tissue samples had been stored in the biorepository between 2010 and 2014. Complete transcriptomes of graft tissues were sequenced and analyzed through RNA sequencing (RNA-seq). The international ImMunoGeneTics information system (IMGT®) was used for in-depth comparison of V(D)J gene segment usage.

Results: The mean age of the 28 KT recipients was 43.3 ± 12.8 years, and 53.6% were male. By family, IGHV3, IGHJ4, IGLV2, and IGLJ3 gene segments were most frequently used in all groups, and their usage was not statistically different among the three patient groups. While IGKV3 was most frequently used in both the ABOiA and ABOiR groups, IGKV1 was most commonly used in the ABOcS group. In addition, while IGKJ1 was most commonly used in the ABOiA and ABOcS groups, IGKJ4 was most frequently used in the ABOiR group. According to individual gene segments, IGHV4-34 and IGHV4-30-2 were more commonly used in the ABOiR group than in the ABOiA group, and IGHV6-1 was more commonly used in the ABOcS group than in the ABOiR group. IGLV7-43 was more commonly used in the ABOcS group than in the ABOi group. However, technical variability, small sample size, and potential confounding effects of Rituximab or HLA mismatching are limitations of our study.

Conclusions: Our findings suggest that RNA-seq transcriptomic analyses can provide information on the V(D)J gene usage of B-cell receptors and the mechanisms of accommodation and immune reaction in ABOi KT.

Keywords: ABO incompatible kidney transplantation; B cell receptor; RNA-seq; VDJ usage.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The running of a biorepository of graft tissue samples of KT patients (H-1102-082-353) and this study (H-1412-029-631) were performed with approval from the Institutional Review Board of Seoul National University Hospital, and evidence of a personally signed and dated informed consent document indicating that the subject had been informed of all pertinent aspects of the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Immunoglobulin heavy chain V and J gene segment family usage in renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated V (a) and J (b) gene segment families in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. IGHV, immunoglobulin heavy chain variable; IGHJ, immunoglobulin heavy chain joining. * P < 0.05
Fig. 2
Fig. 2
Immunoglobulin heavy chain V gene segment usage in renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated gene segment families in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. * P < 0.05
Fig. 3
Fig. 3
Immunoglobulin light kappa chain V and J gene family usage in renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated V (a) and J (b) gene segments in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. IGKV, immunoglobulin light kappa chain variable; IGKJ, immunoglobulin light kappa chain joining. * P < 0.05
Fig. 4
Fig. 4
Immunoglobulin light kappa chain V gene segment usage in renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated gene segments in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. * P < 0.05
Fig. 5
Fig. 5
Immunoglobulin light lambda chain V and J gene family usage renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated V (a) and J (b) gene segments in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. IGLV, immunoglobulin light lambda chain variable; IGLJ, immunoglobulin light lambda chain joining. * P < 0.05
Fig. 6
Fig. 6
Immunoglobulin light lambda chain V gene segment usage in renal allograft tissue transcripts. Percent of unique, in-frame sequences using the indicated gene segment in ABO-incompatible (ABOi) accommodation, ABO-compatible (ABOc) stable, and ABOi rejection groups after kidney transplantation. All comparisons were performed with one-way analysis of variance and post-hoc analyses. * P < 0.05
See this image and copyright information in PMC

References

    1. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl. 2005;1–16. - PubMed
    1. Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation. 1998;65:224–228. doi: 10.1097/00007890-199801270-00014. - DOI - PubMed
    1. Zschiedrich S, Kramer-Zucker A, Janigen B, Seidl M, Emmerich F, Pisarski P, et al. An update on ABO-incompatible kidney transplantation. Transpl Int. 2015;28:387–397. doi: 10.1111/tri.12485. - DOI - PubMed
    1. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-a/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation. 2000;70:1331–1335. doi: 10.1097/00007890-200011150-00011. - DOI - PubMed
    1. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc. 1987;19:4553–4557. - PubMed